These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29271488)

  • 1. Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing.
    Rubio GA; Elliot SJ; Wikramanayake TC; Xia X; Pereira-Simon S; Thaller SR; Glinos GD; Jozic I; Hirt P; Pastar I; Tomic-Canic M; Glassberg MK
    J Cell Physiol; 2018 Aug; 233(8):5503-5512. PubMed ID: 29271488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-fibrotic effects of different sources of MSC in bleomycin-induced lung fibrosis in C57BL6 male mice.
    Periera-Simon S; Xia X; Catanuto P; Coronado R; Kurtzberg J; Bellio M; Lee YS; Khan A; Smith R; Elliot SJ; Glassberg MK
    Respirology; 2021 Feb; 26(2):161-170. PubMed ID: 32851725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis.
    Tashiro J; Elliot SJ; Gerth DJ; Xia X; Pereira-Simon S; Choi R; Catanuto P; Shahzeidi S; Toonkel RL; Shah RH; El Salem F; Glassberg MK
    Transl Res; 2015 Dec; 166(6):554-67. PubMed ID: 26432923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness.
    Chakraborty A; Wang C; Hodgson-Garms M; Broughton BRS; Frith JE; Kelly K; Samuel CS
    Biomed Pharmacother; 2024 Sep; 178():117259. PubMed ID: 39116786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-preconditioned mesenchymal stem cells attenuate bleomycin-induced pulmonary fibrosis.
    Lan YW; Choo KB; Chen CM; Hung TH; Chen YB; Hsieh CH; Kuo HP; Chong KY
    Stem Cell Res Ther; 2015 May; 6(1):97. PubMed ID: 25986930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose-derived stromal/stem cells successfully attenuate the fibrosis of scleroderma mouse models.
    Okamura A; Matsushita T; Komuro A; Kobayashi T; Maeda S; Hamaguchi Y; Takehara K
    Int J Rheum Dis; 2020 Feb; 23(2):216-225. PubMed ID: 31808305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds.
    Qi Y; Jiang D; Sindrilaru A; Stegemann A; Schatz S; Treiber N; Rojewski M; Schrezenmeier H; Vander Beken S; Wlaschek M; Böhm M; Seitz A; Scholz N; Dürselen L; Brinckmann J; Ignatius A; Scharffetter-Kochanek K
    J Invest Dermatol; 2014 Feb; 134(2):526-537. PubMed ID: 23921952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice.
    Huang S; Wu Y; Gao D; Fu X
    Cytotherapy; 2015 Jul; 17(7):922-31. PubMed ID: 25939802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stromal cells from dermal and adipose tissues induce macrophage polarization to a pro-repair phenotype and improve skin wound healing.
    Zomer HD; Jeremias TDS; Ratner B; Trentin AG
    Cytotherapy; 2020 May; 22(5):247-260. PubMed ID: 32234290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA receptor activation inhibits the antifibrotic effect of BM-MSCs on bleomycin-induced pulmonary fibrosis.
    Li X; Li C; Tang Y; Huang Y; Cheng Q; Huang X; Zhao F; Hao C; Feng D; Xu J; Han J; Tang S; Liu W; Yue S; Luo Z
    Am J Physiol Lung Cell Mol Physiol; 2018 Sep; 315(3):L404-L421. PubMed ID: 29722562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Intratracheal Administration of Adipose-derived Stromal Cells on Bleomycin-induced Lung Injury in a Rat Model.
    Uji M; Nakada A; Nakamura T; Hirata K
    Osaka City Med J; 2015 Dec; 61(2):81-91. PubMed ID: 26995852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
    Grandi A; Ferrini E; Zoboli M; Buseghin D; Pennati F; Khalajzeyqami Z; Ciccimarra R; Villetti G; Stellari FF
    Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L736-L753. PubMed ID: 38651940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis.
    Suzuka T; Kotani T; Saito T; Matsuda S; Sato T; Takeuchi T
    Arthritis Res Ther; 2022 Oct; 24(1):228. PubMed ID: 36207753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic acid alleviates pulmonary endoplasmic reticulum stress and epithelial-mesenchymal transition in bleomycin-induced lung fibrosis.
    Tong B; Fu L; Hu B; Zhang ZC; Tan ZX; Li SR; Chen YH; Zhang C; Wang H; Xu DX; Zhao H
    BMC Pulm Med; 2021 May; 21(1):149. PubMed ID: 33952237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte Growth Factor Is Required for Mesenchymal Stromal Cell Protection Against Bleomycin-Induced Pulmonary Fibrosis.
    Cahill EF; Kennelly H; Carty F; Mahon BP; English K
    Stem Cells Transl Med; 2016 Oct; 5(10):1307-1318. PubMed ID: 27388243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
    Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
    Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
    Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
    Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.